![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/395 | (2006.01) |
C07K 16/18 | (2006.01) | ||
G01N 33/577 | (2006.01) | ||
A61P 25/28 | (2006.01) |
(11) | Number of the document | 2361638 |
(13) | Kind of document | T |
(96) | European patent application number | 10196705.7 |
Date of filing the European patent application | 2006-12-08 | |
(97) | Date of publication of the European application | 2011-08-31 |
(45) | Date of publication and mention of the grant of the patent | 2014-01-15 |
(46) | Date of publication of the claims translation | 2014-05-26 |
(30) | Number | Date | Country code |
05027092 | 2005-12-12 | EP | |
06014729 | 2006-07-14 | EP | |
06020766 | 2006-10-02 | EP |
(72) |
Greferath, Ruth, DE
Hickman, David, CH
Muhs, Andreas, CH
Pfeifer, Andrea, CH
Nicolau, Claude, US
|
(73) |
AC Immune S.A.,
EPFL Innovation Park Building B, 1015 Lausanne,
CH
|
(74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | A-beta 1-42 atžvilgiu specifiniai monokloniniai antikūnai, pasižymintys terapinėmis savybėmis |
A beta 1-42 specific monoclonal antibodies with therapeutic properties |
Payment date | Validity (years) | Amount | |
2024-11-21 | 19 | 347.00 EUR |
2025-12-08 |